A retrospective study analyzing association between outcomes of COVID-19 infections among patients with hematological malignancies
Latest Information Update: 11 Oct 2022
At a glance
- Drugs Casirivimab/imdevimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 11 Oct 2022 New trial record
- 01 Oct 2022 Results published in the Clinical Lymphoma, Myeloma & Leukemia